News 13.07.21

PimBio: €0,5M for iPSC-based NMJ-on-a-chip model

PimBio is proud to announce that our NOACH (NMJ-On-A-CHip) consortium under the supervision of Dr. Maartje Huijbers has received a LUMC PPS-Match call Topsector LSH 2021 funding for the development of a patient-derived iPSC-based NMJs-on-a-chip model to study NMJ (patho)physiology by combining functional parameters with a relevant human genetic background.

Read more
News 13.07.21

Inprocess-lsp and DIANT Pharma Inc. finalize Partnership Agreement

DIANT Continuous Nanoparticle Manufacturing System Integrates With InProcess-LSP NanoFlowSizer For Size Characterization. DIANT Pharma Inc. (DIANT), a startup company that provides a turnkey solution for continuous manufacturing of nanoparticles, has the exclusive right to integrate the NanoFlowSizer into the DIANT system, providing a major advantage to DIANT customers. The DIANT system has multiple flow options, up to 100 LPM, and has multiple add-on modules with integrated process analytical technology operating as a single, closed-system.

Read more
News 12.07.21

Citryll enters into bioanalytics partnership with Ardena

Citryll’s first in class antibody drug candidate CIT-013 for autoimmune and chronic inflammatory diseases is beginning its bioanalytical phase at Ardena, a specialist pharmaceutical contract development and manufacturing organisation (CDMO).

Read more
News 05.07.21

Bioconnection: GMP certification for new large scale filling line

BioConnection received from the Dutch Healthcare Inspectorate (IGJ) the GMP certification and manufacturing license for their new large scale filling line

Read more
News 16.06.21

Commercial Agency Agreement between Ardena and South Korean company Keyfronbio Co., Ltd.

Ardena is pleased to announce that a Commercial Agency Agreement for South Korea has been signed with the company Keyfronbio Co., Ltd.

Read more
News 27.05.21

Provincie geeft enorme impuls aan Pivot Park met lening van 37,1 miljoen euro

Voor de bouw van een nieuw pand genaamd Grizzly op Pivot Park in Oss verstrekt de provincie een lening van 37,1 miljoen euro aan de holding van het park. Pivot Park ontwikkelt zich snel en dreig uit haar jasje te groeien. Deze ontwikkeling is dan ook nodig om nu en in toekomst een campus te zijn die aan de verwachtingen en eisen van gebruikers voldoet en om een leidende rol in de wereld van farmacie te kunnen blijven spelen.

Read more
News 26.05.21

Ardena: Investment in Flow Cytometry unlocks the secrets of single cells

Ardena has announced a breakthrough investment in its Flow Cytometry services, greatly expanding their scientific capabilities.

Read more
News 25.05.21

Pivot Park onderdeel van het Brabants succes

FD heeft een mooi artikel gepubliceerd over hoe innovatief en ondernemend Brabanders zijn.

Read more
News 11.05.21

InProcess-LSP and DIANT Pharma Inc. finalize Partnership Agreement

Inprocess LSP is expanding its capabilities as a true PAT solutions provider through a partnership agreement between InProcess-LSP and Diant Pharma Inc. for continuous manufacturing of liposomes and lipid nanoparticles in drug delivery applications such as Covid 19 vaccines manufacturing.

Read more